News

Everyone is worrying about the rising effects of the Red Sea conflict. Most investors will likely see success in following the pop in oil prices through stocks like Hess (NYSE: HES) for reasons

The markets have been on a wild tear so far into the new year, with indices like the S&P 500 and NASDAQ hitting fresh all-time highs. However, not all sectors – and stocks – are created equal in

Crane (NYSE: CR) is a high-flying stock, having gained 58% since the IPO spin-off and keeping most of it. A recent downshift in analyst sentiment driven by valuation capped gains in January

From a technical standpoint, identifying a mid-cap stock that has performed as remarkably and consistently over one year as AppLovin (NYSE: APP) might be difficult.

Impressively, over the

Colgate-Palmolive (NYSE: CL) shares are trending higher within a range and have new highs in sight. The Q4 results, guidance and analysts' sentiment suggest it will set a new multi-year high soon

Every once in a while, stocks get too expensive or too cheap. As the market is a rough estimate of how the underlying United States economy is doing, any of the two extremes could signal that the

Shares of Snowflake Inc. (NYSE: SNOW), a cloud-based data storage, computing, and analytics company, have been impressive lately, with its stock rising almost 50% over the previous three months. 

Intuitive Surgical (NASDAQ: ISRG) share prices surged following the Q4 release but failed to hold the gain, creating an ugly candle capping a strong rally. The market may move lower from here, but

Shares of Logitech International S.A. (NASDAQ: LOGI) fell sharply despite a solid earnings report and improved guidance. The move took share prices to a two-month low, setting up an attractive

Proctor & Gamble’s (NYSE: PG) stock price entered consolidation following the  COVID-19 bubble, but its uptrend is intact, and a trend-following signal is in play. Because the stock has sustained

Gene therapy will get its share of the spotlight in the medical sector in 2024. The FDA approval for Casgevy, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) and CRISPR Therapeutics AG (NASDAQ: CRSP)

Johnson & Johnson (NYSE: JNJ) had a solid quarter in Q4 despite the impacts of the Kenvue spin-off and the deleveraging of COVID-19 sales. However, little has emerged to catalyze the bulls

2023 was a year to forget for the personal care industry. With traders clamoring for growth-oriented technology and media shares, the defensive group became an afterthought and woefully

Applied Digital Co. (NASDAQ: APLD) shares experienced a 4X surge in 2023, riding the artificial intelligence (AI) trend as a provider of next-generation AI data centers. Its data centers were

Shares of Birkenstock Holdings plc (NYSE: BIRK) made a decent recovery after falling more than 10% from its closing price of $50 on January 17, 2024. The reason for the stock's decline was the

In the fall of 2023, Intuitive Surgical, Inc. (NASDAQ: ISRG) was among a group of health care provider and food manufacturer stocks crushed by Ozempic fears. The prevailing mindset was that rising

Hiring struggles. Supply chain issues. Food cost inflation.

These are just some of the challenges faced by U.S. quick service restaurants (QSRs) in 2023. To the group’s credit though, restaurants

Morgan Stanley’s (NYSE: MS) Q4 results were mixed relative to the analysts' estimates but give no reason to fear a stock price correction. The stock price may move lower before it moves higher

Identifying the right dividend stock for your investment strategy can be like finding a needle in a haystack. You know you want an equity that makes regular cash payouts — but where do you go from

Surgery Partners Inc. (NASDAQ: SGRY) is a leading healthcare services provider that owns and operates over 180 outpatient surgical centers in 31 states. Its integrated delivery model includes

Some industries refuse to change and invest in innovative technologies; it is sometimes valuable and helpful to adopt the 'If it's not broke, don't fix it' mentality; however, sometimes, it can

A 3% drop by lunchtime on Friday should tell you everything you need to know about the market's reaction to Wells Fargo & Company's (NYSE: WFC) earnings report. While the finer details will need

Delta Air Lines (NYSE: DAL) shares fell more than 5% following the Q4 earnings release, creating a buy-the-dip opportunity. The release contained nothing but good news and an optimistic outlook